The Kaplan–Meier analysis showed that only STK11 expression levels were significantly associated with the clinical outcome (Figure 6) and that its expression was highly heterogeneous in normal vs. tumor samples, although this differences were not significant while miR-100-3p and -5p showed no association with the clinical outcome. The gene discussed is STK11; the disease is neoplasm.